NASDAQCommunication ServicesAdvertising AgenciesSnapshot 2026-07-23
Reading CDLX? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a speculative growth opportunity. The current thesis state is cautious, as the company has shown erratic performance and is navigating significant risks.
The market currently prices in a low level of fragility, suggesting that there are no immediate concerns about stability. However, CDLX is seen as cheap compared to its peers, with a notable expectations gap indicating that investors may not fully anticipate future challenges.
Fundamentals are expected to remain under pressure due to ongoing losses and a high risk environment. Recent financial performance has been neutral, but there is a near-term risk of missing earnings expectations, which is significant given the company's history of erratic results.
The long-term thesis hinges on management's ability to stabilize operations and meet Nasdaq listing requirements. Additionally, external factors such as potential interest rate cuts and performance from sector leaders could influence CDLX's trajectory.
In the next 1 to 3 years, CDLX must navigate its operational challenges while leveraging favorable market conditions to improve its standing. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: The outcome will decide if Cardlytics stays listed or gets delisted.
Confirms:Nasdaq says Cardlytics has met the minimum bid price rule.
Disproves:Nasdaq delists Cardlytics for not meeting listing standards.
Why it matters: Billings are a key metric for Cardlytics. A drop below guidance signals ongoing struggles.
Confirms:Q2 2026 billings reported below $61 million.
Disproves:Q2 2026 billings reported above $67 million.
Why it matters: Earnings results will show financial health and future plans.
Confirms one read:Earnings report shows revenue growth and positive guidance.
Confirms the other:Earnings report shows revenue decline or bad guidance.
Why it matters: The reverse stock split affects share price and market perception. It could impact investor confidence.
Confirms one read:The stock trades above $1.00 per share after the split is completed.
Confirms the other:The stock remains below $1.00 per share after the split.
Why it matters: Earnings results will show if the company is making more money.
Confirms one read:Earnings report shows revenue growth or positive guidance.
Confirms the other:Earnings report shows revenue is still falling or gives negative guidance.
Why it matters: Progress on meeting Nasdaq requirements is critical for the company's future. Failure to address these could lead to delisting.
Confirms:Management says they are making progress on Nasdaq listing rules. More updates will come.
Disproves:No news or progress on Nasdaq listing rules has been shared.
Why it matters: A successful reverse stock split could help Cardlytics meet Nasdaq rules.
Confirms:The company completes the 1-for-10 reverse stock split as planned.
Disproves:The company fails to complete the reverse stock split by the deadline.
Why it matters: The earnings report will provide insights into financial health and future guidance. It can shift investor sentiment.
Confirms one read:The earnings report shows revenue is growing. Financial numbers are better than in past quarters.
Confirms the other:Earnings report shows continued revenue decline or weak guidance.
Why it matters: MQUs are vital for revenue growth. An increase indicates better user engagement.
Confirms:MQUs reported above 197 million in Q2 2026.
Disproves:MQUs reported below 197 million in Q2 2026.
